{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:16:36Z","timestamp":1778224596630,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd001245.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000}}],"reference-count":60,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001245.pub3","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:17:10Z","timestamp":1667978230000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage"],"prefix":"10.1002","volume":"2022","author":[{"given":"Menno R","family":"Germans","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; University Hospital Zurich; Zurich Switzerland"},{"name":"Clinical Neuroscience Center; University Hospital Zurich; Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter J","family":"Dronkers","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Amsterdam UMC location University of Amsterdam; Amsterdam Netherlands"},{"name":"Amsterdam Neuroscience, Neurovascular Disorders; Amsterdam Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merih I","family":"Baharoglu","sequence":"additional","affiliation":[{"name":"Amsterdam Neuroscience, Neurovascular Disorders; Amsterdam Netherlands"},{"name":"Department of Neurology; Amsterdam UMC location University of Amsterdam; Amsterdam Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Post","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Amsterdam UMC location University of Amsterdam; Amsterdam Netherlands"},{"name":"Amsterdam Neuroscience, Neurovascular Disorders; Amsterdam Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Verbaan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Amsterdam UMC location University of Amsterdam; Amsterdam Netherlands"},{"name":"Amsterdam Neuroscience, Neurovascular Disorders; Amsterdam Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel JE","family":"Rinkel","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosurgery; University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvo BWEM","family":"Roos","sequence":"additional","affiliation":[{"name":"Amsterdam Neuroscience, Neurovascular Disorders; Amsterdam Netherlands"},{"name":"Department of Neurology; Amsterdam UMC location University of Amsterdam; Amsterdam Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"10.1002\/14651858.CD001245.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ana.410030607","article-title":"Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial","volume":"3","author":"Chandra","year":"1978","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/00006123-198102000-00004","article-title":"Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial","volume":"8","author":"Fodstad","year":"1981","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0003|cit3","first-page":"150","article-title":"The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms","volume":"98","author":"Girvin","year":"1973","journal-title":"Transactions of the American Neurological Association"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study","volume":"97","author":"Hillman","year":"2002","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.STR.10.5.519","article-title":"Tranexamic acid in subarachnoid hemorrhage. A double-blind study","volume":"10","author":"Kaste","year":"1979","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/bmj.1.6118.945","article-title":"Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?","volume":"1","author":"Maurice-Williams","year":"1978","journal-title":"British Medical Journal"},{"issue":"143","key":"10.1002\/14651858.CD001245.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-14-143","article-title":"Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial","volume":"14","author":"Germans","year":"2013","journal-title":"Trials"},{"issue":"10269","key":"10.1002\/14651858.CD001245.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","article-title":"Ultra-early tranexamic acid after subarachnoid haemorrhage: a randomised controlled clinical trial","volume":"397","author":"Post","year":"2021","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0009|cit9","unstructured":"Tjerkstra MA Post R Germans MR Vergouwen MD Jellema K Koot RW Tranexamic acid after aneurysmal subarachnoid hemorrhage: post-hoc analysis of the ULTRA trial Neurology 10.1212\/WNL.0000000000201160"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.54.1.77","article-title":"Antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage: a randomized placebo-controlled trial","volume":"54","author":"Roos","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01402177","article-title":"Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study","volume":"102","author":"Tsementzis","year":"1990","journal-title":"Acta Neurochirurgica"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01407517","article-title":"Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid","volume":"103","author":"Tsementzis","year":"1990","journal-title":"Acta Neurochirurgica"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410020311","article-title":"Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial","volume":"2","author":"Van Rossum","year":"1977","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM198408163110703","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage","volume":"311","author":"Vermeulen","year":"1984","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.1981.00510010051009","article-title":"Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study","volume":"38","author":"Nibbelink","year":"1981","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD001245.pub3-BIB0016|cit16","first-page":"53","article-title":"Results of Trasylol treatment of subarachnoid hemorrhage","volume":"29","author":"Brzecki","year":"1974","journal-title":"Polski Tygodnik Lekarski"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(79)91204-2","article-title":"Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid","volume":"1","author":"Chowdhary","year":"1979","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jnnp.44.9.810","article-title":"Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage","volume":"44","author":"Chowdhary","year":"1981","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/153857448602000102","article-title":"Prevention of early recurrence of aneurysmal subarachnoid haemorrhage by tranexamic acid: a controlled clinical trial","volume":"1","author":"Chowdhary","year":"1986","journal-title":"Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD001245.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.annemergmed.2014.06.004","article-title":"Are antifibrinolytic agents effective in the treatment of aneurysmal subarachnoid hemorrhage?","volume":"64","author":"Eastin","year":"2014","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0021|cit21","first-page":"9","article-title":"Tranexamic acid in the preoperative management of ruptured intracranial aneurysms","volume":"10","author":"Fodstad","year":"1978","journal-title":"Surgical Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01400945","article-title":"Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid","volume":"52","author":"Gelmers","year":"1980","journal-title":"Acta Neurochirurgica"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.STR.13.2.256","article-title":"Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage","volume":"13","author":"Adams","year":"1982","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1987.00520130088024","article-title":"Antifibrinolytics in aneurysmal subarachnoid hemorrhage. Do they have a role? Maybe","volume":"44","author":"Adams","year":"1987","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/01.STR.19.10.1300","article-title":"Management of aneurysmal subarachnoid hemorrhage","volume":"19","author":"Biller","year":"1988","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/emj.2005.023523","article-title":"Best evidence topic report. Antifibrinolytics for the initial management of sub arachnoid haemorrhage","volume":"22","author":"Carley","year":"2005","journal-title":"Emergency Medicine Journal"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12028-008-9088-5","article-title":"Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage","volume":"8","author":"Chawjol","year":"2008","journal-title":"Neurocritical Care"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01728877","article-title":"Antifibrinolytic treatment in subarachnoid haemorrhage: present state","volume":"63","author":"Fodstad","year":"1982","journal-title":"Acta Neurochirurgica"},{"issue":"1","key":"10.1002\/14651858.CD001245.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00701-011-1179-y","article-title":"Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis","volume":"154","author":"Gaberel","year":"2012","journal-title":"Acta Neurochirurgica"},{"issue":"143","key":"10.1002\/14651858.CD001245.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-14-143","article-title":"Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial","volume":"14","author":"Germans","year":"2013","journal-title":"Trials"},{"issue":"7","key":"10.1002\/14651858.CD001245.pub3-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00415-014-7365-0","article-title":"Time intervals from subarachnoid hemorrhage to rebleed","volume":"261","author":"Germans","year":"2014","journal-title":"Jornal of Neurology"},{"issue":"506","key":"10.1002\/14651858.CD001245.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/pgmj.43.506.779","article-title":"Fibrinolysis in subarachnoid haemorrhage","volume":"43","author":"Gibbs","year":"1967","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.wneu.2011.03.025","article-title":"Risk factors related to aneurysmal rebleeding","volume":"76","author":"Guo","year":"2011","journal-title":"World Neurosurgery"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0035|cit35","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/ www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0036|cit36","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0037|cit37","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021\u00a0 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00314000","article-title":"Antifibrinolytic agents in subarachnoid haemorrhage","volume":"234","author":"Lindsay","year":"1987","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3171\/jns.1966.25.3.0321","article-title":"Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations","volume":"25","author":"Locksley","year":"1966","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10641960600549686","article-title":"Treatment of intracranial aneurysms","volume":"28","author":"Maira","year":"2006","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/01.CIR.90.5.2592","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association","volume":"90","author":"Mayberg","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD001245.pub3-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3171\/jns.1968.28.1.0021","article-title":"Antifibrinolytic therapy for intracranial aneurysms","volume":"28","author":"Mullan","year":"1967","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archneur.62.3.410","article-title":"Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage","volume":"62","author":"Naidech","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.31.3.316","article-title":"Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm","volume":"31","author":"Ramirez-Lassepas","year":"1981","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0045|cit45","first-page":"1","article-title":"Safety and efficacy of tranexamic acid in aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials","volume":"12","author":"Ren","year":"2021","journal-title":"Forntiers in Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0046|cit46","unstructured":"Review Manager Web 5 (RevMan Web 5) The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1747-4949.2008.00210.x","article-title":"Medical management of patients with aneurysmal subarachnoid haemorrhage","volume":"3","author":"Rinkel","year":"2008","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jnnp.68.3.337","article-title":"Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands","volume":"68","author":"Roos","year":"2000","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001245.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/STROKEAHA.117.019328","article-title":"Predictors of in-hospital death after aneurysmal subarachnoid hemorrhage: analysis of a nationwide database (Swiss SOS [Swiss Study on Aneurysmal Subarachnoid Hemorrhage])","volume":"49","author":"Stienen","year":"2018","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/124.2.249","article-title":"Subarachnoid haemorrhage: diagnosis, causes and management","volume":"124","author":"Van Gijn","year":"2001","journal-title":"Brain"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","article-title":"Subarachnoid haemorrhage","volume":"369","author":"Van Gijn","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD001245.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0303-8467(80)90056-6","article-title":"Do antifibrinolytic agents prevent rebleeding after rupture of a cerebral aneurysm? A review","volume":"82","author":"Vermeulen","year":"1980","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1212\/WNL.33.1.112","article-title":"Spectrophotometric analysis of CSF after subarachnoid hemorrhage: limitations in the diagnosis of rebleeding","volume":"33","author":"Vermeulen","year":"1983","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00886869","article-title":"Subarachnoid haemorrhage: diagnosis and treatment","volume":"243","author":"Vermeulen","year":"1996","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-510X(94)90024-8","article-title":"Subarachnoid hemorrhage: an update of pathogenesis, diagnosis and management","volume":"125","author":"Weaver","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archneur.1987.00520130090025","article-title":"Antifibrinolytics in subarachnoid hemorrhage. Do they have a role? No","volume":"44","author":"Weir","year":"1987","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD001245.pub3-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001245.pub2","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage\u00a0","author":"Baharoglu","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001245.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/jnnp.65.6.942","article-title":"Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage","volume":"65","author":"Roos","year":"1998","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001245.pub3-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","author":"Roos","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:37:51Z","timestamp":1759793871000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001245.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001245.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}